Skip to content
HowShorted

CNS Pharmaceuticals, Inc. short interest in 2020

In 2020, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 0.67% of shares outstanding on 15 Apr 2020 to 0.74% on 31 Dec 2020, a change of +0.07 percentage points. The year's high was 0.88% on 15 Jun 2020 and its low 0.39% on 15 Dec 2020, averaging 0.57% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.84 days on 15 May 2020. Full history: CNS Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CNS Pharmaceuticals, Inc. in 2020

2020 in figures

Start of year
0.67% (15 Apr 2020)
End of year
0.74% (31 Dec 2020)
Change
+0.07 pp
High
0.88% (15 Jun 2020)
Low
0.39% (15 Dec 2020)
Average
0.57%
Highest days to cover
14.84 (15 May 2020)
SEC filings marked
5

Every report in 2020

CNS Pharmaceuticals, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Apr 20200.67%1.0010-K filed, results (8-K)
30 Apr 20200.47%1.00
15 May 20200.49%14.8410-Q filed
29 May 20200.60%4.27
15 Jun 20200.88%1.00
30 Jun 20200.61%2.01
15 Jul 20200.52%1.45
31 Jul 20200.62%1.46
14 Aug 20200.56%1.9710-Q filed
31 Aug 20200.74%1.00
15 Sep 20200.55%1.07
30 Sep 20200.52%2.57
15 Oct 20200.46%2.62
30 Oct 20200.46%5.14
13 Nov 20200.48%1.3810-Q filed
30 Nov 20200.41%1.00
15 Dec 20200.39%1.00
31 Dec 20200.74%1.00

See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.